RXi Pharmaceuticals (RXII -26%) tanks after announcing it plans to split into two publicly...

|By:, SA News Editor

RXi Pharmaceuticals (RXII -26%) tanks after announcing it plans to split into two publicly traded companies later this year, separating its oncology and gene therapy businesses.